GCGiulio Camarlinghi

Giulio Camarlinghi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giulio Camarlinghi has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changing in Blood Cells for Infection Detection: The Significance of “Monocyte Distribution Width” in Sepsis Prevention

    by Agostino Ognibene, Maria Lorubbio, Sara Montemerani, Tommaso Novi, Giulio Camarlinghi, Claudia Artini, Laura Bernini, Eva Maria Parisio, Raffaella Pavani, Danilo Tacconi, et al.

    Background/Objectives: Blood is often the first organ to show changes during local or systemic infection, but common definitions of sepsis rarely include CBC findings in risk assessment tools. Infection remains the main cause of sepsis, which Sepsis-3 defines as life-threatening organ dysfunction from a dysregulated immune response. Changes in circulating monocytes—such as altered MDW and increased inflammation—can be seen in sepsis and SARS-COV-2. This study evaluates MDW as a blood marker for detecting infections and compares it with traditional markers for risk stratification. Methods: From December 2021 to December 2023, 608 adults with suspected infection or sepsis were enrolled at San Donato Hospital's Emergency Department in Arezzo. All patients were admitted and monitored in assigned wards, with destination, history, clinical, and lab data collected during their stay and follow-up. Results: Monocyte Distribution Width (MDW) detects bloodstream infection with high efficacy (sensitivity 92%, specificity 85%, and negative predictive value 95% at ER admission). MDW also stratifies risk for infections that may progress to sepsis—including urinary, respiratory, post-surgical, and wound infections—with sensitivity, specificity, and negative predictive value around 70–72%. Conclusions: Blood is usually the first organ to show changes during infection, with blood cell morphology and CBC parameters affected by bacterial, viral, or fungal pathogens. Techniques like flow cytometry and impedance measurements provide Cell Population Data (CPD), such as MDW, which support diagnostic algorithms for infection or sepsis. CPDs are well-suited for AI analysis, and the extensive information from CBCs should be integrated into both diagnosis and treatment.

  • Open Access

    Follow the Path: Unveiling an Azole Resistant Candida parapsilosis Outbreak by FTIR Spectroscopy and STR Analysis

    by Elena De Carolis, Carlotta Magrì, Giulio Camarlinghi, Vittorio Ivagnes, Bram Spruijtenburg, Eelco F. J. Meijer, Cristiano Scarselli, Eva Maria Parisio, Maurizio Sanguinetti

    Accurate identification and rapid genotyping of Candida parapsilosis, a significant opportunistic pathogen in healthcare settings, is crucial for managing outbreaks, timely intervention, and effective infection control measures. This study includes 24 clinical samples and 2 positive environmental surveillance swabs collected during a fluconazole-resistant Candida parapsilosis outbreak at the Tuscany Rehabilitation Clinic (Clinica di Riabilitazione Toscana, CRT), located in the province of Arezzo, Italy. Fourier-transform infrared (FTIR) spectroscopy, genetic sequencing of the ERG11 gene, and short tandem repeat (STR) analysis was applied to track the fluconazole-resistant C. parapsilosis outbreak at the CRT facility. FTIR analysis clustered the isolates into two major groups, correlating with resistance-associated ERG11 mutations (Y132F and R398I), azole resistance levels, and year of isolation. The combined use of FTIR spectroscopy and STR typing provided a comprehensive approach to identify and track fluconazole-resistant C. parapsilosis isolates, which identified specific clusters of genetically similar isolates. By comparison with feasible molecular techniques, we conclude that FTIR spectroscopy applied in real time can inform targeted infection control strategies and aid in the effective management of nosocomial infections.


    • 1 June 2024
      • Vol. 47  (2) , 172-179

    Hepatitis C Virus (HCV) genotypes distribution in South-Eastern Tuscany: a ten-year retrospective study

    by Agostino Ognibene, Giulio Camarlinghi, Maria Lorubbio, Manuela Mafucci, Alessandro Saracini, Alessandro Pancrazzi, Silvana Gervino, Gianluca Viti, Augusto Maddalena, Danilo Tacconi, et al.

    Italy is recognized as having the highest Hepatitis C virus (HCV) prevalence in Europe. The Tuscany region, where the prevalence of HCV infection is approximately 0.8%, implemented two programs for the control of chronic hepatitis C in Tuscany from 2018 to 2022. This retrospective study aims to investigate the incidence of HCV in a population screened in Southeastern Tuscany from 2013 to 2022. The study population included 246,137 patients from the provincial area of Arezzo and Grosseto, Tuscany, spanning from January 2013 to October 2022. Among the subjects included in the study, 3,190 (1.29%) tested positive for anti-HCV antibodies. Of this population, 2,119 patients (66.43%) also tested positive for HCV-RNA quantification, leading to their enrolment for subsequent viral genotyping. 1,106 patients had genotype (GT) 1 (52.2%), 484 had GT 3 (22.8%), 371 had GT 2 (17.5%), and 158 had GT 4 (7.5%). Our study underscores the prevalence of HCV GTs 1 and 3 as the most predominant GTs in the Southeast Tuscany region. We also observe a correlation between age, sex and HCV genotypic distribution.


  • Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey

    by Stefano Di Bella, Roberta Maria Antonello, Gianfranco Sanson, Alberto Enrico Maraolo, Daniele Roberto Giacobbe, Chiara Sepulcri, Simone Ambretti, Richard Aschbacher, Laura Bartolini, Mariano Bernardo, et al.